Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EnteroMedics Inc    ETRM

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 1,19 M
EBIT 2016 -27,6 M
Net income 2016 -
Debt 2016 -
Yield 2016 -
Sales 2017 2,39 M
EBIT 2017 -30,1 M
Net income 2017 -
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 4,63x
Capi. / Sales2017 2,30x
Capitalization 5,49 M
More Financials
Company
EnteroMedics, Inc. is a clinical development stage medical device company that engages in the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.Its proprietary neuroblocking technology is designed to... 
More about the company
Surperformance© ratings of EnteroMedics Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on ENTEROMEDICS INC
11/22 ENTEROMEDICS INC : Other Events, Financial Statements and Exhibits (form 8-K)
11/17 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Other Events
11/16 ENTEROMEDICS INC : Other Events (form 8-K)
11/14 ENTEROMEDICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
11/10 ENTEROMEDICS INC. (NASDAQ : ETRM) Files An 8-K Reports Third Quarter 2016 Financ..
11/10 ENTEROMEDICS INC : Results of Operations and Financial Condition, Financial Stat..
11/10 ENTEROMEDICS : reports 3Q loss
11/08 ENTEROMEDICS INC : Change in Directors or Principal Officers (form 8-K)
11/01 ENTEROMEDICS INC : Other Events (form 8-K)
10/19 ENTEROMEDICS INC : Other Events (form 8-K)
More news
Sector news : Advanced Medical Equipment & Technology - NEC
12/02 Deals scuppered by U.S. regulatory scrutiny
11/29 European spin-offs and carve-outs
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
11/15 Exclusive - EU regulators seen clearing $25 billion Abbott, St Jude deal
11/02DJU.S. HOT STOCKS : Hot Stocks to Watch
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
01/05 Medtech Approvals Of The Strange Kind
2015 EnteroMedics Will Do 1 For 15 Reverse Split - This Is Not A Good Way To Start..
2015 ENTEROMEDICS TO REVERSE SPLIT SHARES : 15
2015 EnteroMedics' (ETRM) CEO Dan Gladney on Q3 2015 Results - Earnings Call Trans..
2015 EnteroMedics - Investors Need To Have Realistic Expectations
Advertisement
Chart ENTEROMEDICS INC
Duration : Period :
EnteroMedics Inc Technical Analysis Chart | ETRM | US29365M2089 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 1,10 $
Spread / Average Target 2 168%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Dan W. Gladney Chairman, President & Chief Executive Officer
Peter M. Delange Senior VP-Operations & Business Development
Scott P. Youngstrom Chief Financial & Compliance Officer
Carl Samuel Goldfischer Independent Class I Director
Nicholas L. Teti Independent Class III Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENTEROMEDICS INC53.73%5
THERMO FISHER SCIENTIF..-1.23%56 058
DANAHER CORPORATION9.60%53 482
BOSTON SCIENTIFIC CORP..10.95%27 710
PHILIPS15.05%26 897
INTUITIVE SURGICAL, IN..16.57%24 668
More Results